Sun Pharma consolidated net dips by 12% in Q2

Sun Pharmaceutical Industries, a Rs 4,275 crore pharmaceutical major, has suffered heavy setback during second quarter ended September 2009 and its consolidated net profit declined by 11.5 per cent to Rs 453.81 crore from Rs 512.77 crore in the corresponding period of last year. Its net sales remained stagnant at Rs 1,185 crore as against Rs 1,178 crore in the last period. With fall in profits, its EPS nosedived to Rs 21.9 from Rs 24.8 in the last period.

Comments

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying